Strategies for Simultaneous Display and Secretion of Antibodies in CHO
This research can significantly improve how therapeutic antibodies are developed and manufactured. By enabling faster and more reliable screening of antibody candidates directly in production-like cells, our approach can reduce development time, lower manufacturing risk, and potentially decrease overall costs associated with failed drug candidates. More broadly, this platform supports innovation in biologics development and enhance competitiveness in the biopharmaceutical sector.
Read more: https://www.a-star.edu.sg/bti/bti-research-highlights/strategies-for-simultaneous-display-and-secretion-of-antibodies-in-cho
